Inflection Biosciences
PrivateLast Round
Seed
Mar 9, 2015
Total Funding Raised
$1.38M
Company Overview
Inflection Biosciences operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Seed round in March 2015.
Inflection Biosciences is a biotechnology company that develops small molecule therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inflection Biosciences Comparables
Compare Inflection Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synnovation Therapeutics | 80% | |
| AUM Biosciences | 78% | |
| Ability Pharmaceuticals | 77% |
For institutional investors. Book with your work email.
Inflection Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 9, 2015 | ||||
| Seed | Jun 4, 2013 |
For institutional investors. Book with your work email.
Inflection Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Enterprise Ireland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2015
$790K raised in Seed round.
- Jun 4, 2013
$590K round with Enterprise Ireland as an investor.
For institutional investors. Book with your work email.
Inflection Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inflection Biosciences's valuation, stock price, and market status.
Is Inflection Biosciences a public or private company?
Inflection Biosciences is a private company.
What is the current stock price of Inflection Biosciences?
Inflection Biosciences is a private company, so its shares have no public market price. Caplight tracks Inflection Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inflection Biosciences worth (valuation)?
Valuation information for Inflection Biosciences is not publicly available.
Can I buy Inflection Biosciences stock?
Inflection Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inflection Biosciences's last funding round?
Inflection Biosciences's most recent funding round was Seed on March 9, 2015.
Who are the main investors in Inflection Biosciences?
Key investors in Inflection Biosciences include European Commission, Enterprise Ireland.
Will Inflection Biosciences IPO soon?
No public IPO plans have been announced for Inflection Biosciences.
How can I track Inflection Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Inflection Biosciences's shares on secondary markets.